In a recent study, researchers reviewed magnetic resonance images (MRI) of muscle injuries experienced by athletes during the Tokyo Olympic Games and found that when muscle injuries were characterized by torn fibers extending ...
Jan 18, 2023
0
16
Warfarin, the longtime standard treatment for atrial fibrillation, is facing competition from new options in the anticoagulant drug marketplace including dabigatran, rivaroxaban, and apixaban. A new study documents the rapid ...
Aug 19, 2014
0
0
Britain's competition watchdog accused GlaxoSmithKline on Friday of paying off competitors to delay launches of their own versions of GSK's best-selling antidepressant, Seroxat.
Apr 19, 2013
1
0
In a recent letter, Richard Pound, the longest-serving member of the International Olympic Committee, claimed that "the IOC is athlete-centered," insisting the Olympics "can—and do—make the world a better place."
Feb 18, 2022
0
0
Problem-plagued Ranbaxy Pharmaceuticals Inc. has halted production of generic cholesterol drug Lipitor while it investigates how tiny glass particles got into the ingredients used for dozens of batches of the drug that were ...
Nov 30, 2012
0
0
Educating athletes, parents and coaches about concussion treatment and prevention has been a priority during the last decade, but are the intended audiences hearing the message?
May 4, 2021
0
5
With summer ablaze and recent World Cup fever stoking inspiration, soccer fields are sites of athleticism, friendships and fun. But for some parents, soccer has also become a source of tension.
Jul 16, 2019
0
3
(AP)—Drug giant Pfizer Inc. said Thursday that its third-quarter profit fell 14 percent as sales plunged, mainly due to U.S. generic competition to cholesterol fighter Lipitor, long the world's top-selling drug.
Nov 1, 2012
0
0
(Medical Xpress) -- A new study from Washington University in St. Louis suggests that health insurance exchanges, a key provision of the Affordable Care Act passed in 2010, may need to be monitored to make sure there is sufficient ...
Jun 5, 2012
0
0
(AP)—Anglo-Swedish pharmaceutical company AstraZeneca PLC warned over expiring patents on its medicines as the company announced a 37 percent fall in full-year net profit on Thursday.
Jan 31, 2013
0
0
